Literature DB >> 27277235

Effects of a vertical console position on operator muscular stress during ultrasonic diagnosis.

Hiroyuki Suzuki1, Takayoshi Saito2, Yoshihiro Shimomura3, Tetsuo Katsuura3.   

Abstract

Ultrasound examinations tend to put sonographers in unnatural postures, which may lead to musculoskeletal disorders. In this study, we focused on the height of the operation panel of the diagnostic ultrasound system to quantitatively assess the effects of panel height (work plane height) on musculoskeletal stress during scanning in a sitting position. Eight subjects were asked to perform a simulated scanning task that involved touching nine points on the operation panel at four different panel heights. Electromyogram, left wrist joint angle, and subjective evaluation on ease of manipulation, etc., indicated that the optimum height of the operation panel during scanning in a sitting position is elbow height.

Entities:  

Keywords:  Diagnostic ultrasound system; Ergonomics; Height from the floor; Muscular stress; Operation panel; Working environment

Year:  2012        PMID: 27277235     DOI: 10.1007/s10396-012-0415-2

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  1 in total

1.  Work-related musculoskeletal complaints in sonologists.

Authors:  N Magnavita; L Bevilacqua; P Mirk; A Fileni; N Castellino
Journal:  J Occup Environ Med       Date:  1999-11       Impact factor: 2.162

  1 in total
  2 in total

1.  Effects of horizontal console position on operator muscular stress during abdominal ultrasonic diagnosis.

Authors:  Hiroyuki Suzuki; Takayoshi Saito; Yoshihiro Shimomura; Tetsuo Katsuura
Journal:  J Med Ultrason (2001)       Date:  2013-10-01       Impact factor: 1.314

2.  The Prevalence of and Risk Factors Associated with Musculoskeletal Disorders among Sonographers in Central China: A Cross-Sectional Study.

Authors:  Qingmin Feng; Shenglin Liu; Lei Yang; Mingxing Xie; Qiang Zhang
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.